Next Article in Journal
Internet Mindfulness Meditation Intervention (IMMI) Improves Depression Symptoms in Older Adults
Next Article in Special Issue
Pathogenic Viruses Commonly Present in the Oral Cavity and Relevant Antiviral Compounds Derived from Natural Products
Previous Article in Journal / Special Issue
Changes in Metabolic Profiles of Human Oral Cells by Benzylidene Ascorbates and Eugenol
Open AccessReview

New Functions of Classical Compounds against Orofacial Inflammatory Lesions

1
Department of Oral and Maxillofacial Reconstructive Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan
2
Department of Biomaterials, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan
3
Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan
*
Author to whom correspondence should be addressed.
Medicines 2018, 5(4), 118; https://doi.org/10.3390/medicines5040118
Received: 13 September 2018 / Revised: 11 October 2018 / Accepted: 13 October 2018 / Published: 1 November 2018
Anti-inflammatory agents have been widely used to ameliorate severe inflammatory symptoms of a number of diseases, and such therapeutics are particularly useful for diseases with intolerable pain without significant mortality. A typical example of this is a disease known as stomatitis; although stomatitis itself is not a life-threatening disease, it severely impairs the individual’s quality of life, and thus a standard therapeutic strategy for it has already been established. The topical application of a bioactive agent is quite easy, and a strong anti-inflammatory agent can be used without significant adverse effects. In contrast, natural products with relatively mild bioactivity are used for systemic intervention. However, new aspects of classical drugs used in these established therapeutic methods have recently been discovered, which is expanding the utility of these compounds to other oral diseases such as osteoarthritis of temporomandibular joints (TMJ-OA). In this review article, after summarizing the general concept and pathobiology of stomatitis, its established therapeutics are explained. Thereafter, recent advances in the research into related compounds, which is uncovering new biological functions of the agents used therein, are introduced. Indeed, regenerative therapeutics for TMJ-OA may be developed with the classical compounds currently being used. View Full-Text
Keywords: stomatitis; recurrent aphthous stomatitis; oral lichen planus; CCN2; glucocorticoids; alkaloids stomatitis; recurrent aphthous stomatitis; oral lichen planus; CCN2; glucocorticoids; alkaloids
Show Figures

Figure 1

MDPI and ACS Style

Moritani, N.H.; Hara, E.S.; Kubota, S. New Functions of Classical Compounds against Orofacial Inflammatory Lesions. Medicines 2018, 5, 118.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop